Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	12.39	123.96	110.29
Graham Fair Price	17.88	5.21	4.42
PEG	82.82	1.81	0.99
Price/Book	22.66	43.97	35.84
Price/Cash Flow	5.31	144.27	137.00
Prices/Earnings	15.79	36.30	31.35
Price/Sales	19.03	82.96	69.70
Price/FCF	5.31	144.27	137.00
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.74	0.79	0.76
Operating Margin	6.27	0.65	0.62
ROA	3.30	0.19	0.19
ROE	0.29	0.30	5.94
ROIC	0.22	0.25	11.33
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	123.55
Dividends QOQ	0.02	< 0.005	-60.40
EBIT QOQ	0.31	0.25	-17.87
EPS QOQ	0.32	0.20	-36.67
FCF QOQ	0.59	0.33	-44.16
Revenue QOQ	0.22	0.18	-18.88
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	89.49	95.63	6.85
Days Sales Outstanding (DSO)	40.71	42.73	4.95
Inventory Turnover	1.01	0.94	-6.41
Debt/Capitalization	0.19	0.16	-12.14
Quick Ratio	3.38	2.88	-14.99
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.74	2.00	14.53
Cash	1.05	1.28	21.19
Capex	-0.01	-0.01	-45.51
Free Cash Flow	0.46	0.61	33.40
Revenue	0.90	1.06	18.02
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.17	3.53	-15.39
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.27	0.19	-27.70
Naive Interpretation	Member

06 - Financial Health · Bad

Rating